AI-Driven CHARM’s Number One Goal: Transitioning To A Clinical-Stage Biotech
Executive Summary
Laksh Aithani, CEO of CHARM Therapeutics, discusses key challenges for the flourishing AI drug development sector including finding the right people and the need for more success stories.